Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somavaratan in Japanese Children with GHD
NCT02413138Phase 3Terminated
- Sponsor
- Versartis, Inc.
- Start
- Aug 2015
- Primary completion
- Nov 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of somavaratan in growth hormone deficiency (GHD), sponsored by Versartis, Inc.. Started Aug 2015; status: terminated.
02
Drugs
somavaratan
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT02413138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02413138.